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Scarless healing of cutaneous wounds occurs in humans
during the first two trimesters of development, but by
birth all wounds are repaired with scar formation. To
search for transcriptional regulatory genes that might
mediate fetal tissue regeneration, we surveyed homeobox
gene expression in proliferating fetal fibroblasts and in
wounded and unwounded skin. Two novel human
homeobox genes, PRX-2 and HOXB13, were identified
that were differentially expressed during fetal versus
adult wound healing. Both genes were predominantly
expressed in proliferating fetal fibroblasts and developing
dermis, and PRX-2 was downregulated in adult skin.
In a model of scarless fetal skin regeneration, PRX-2
The wound healing process is phylogenetically anddevelopmentally coordinated. In adult mammals, woundhealing is characterized by irregular collagen depositionand scar formation. In contrast, amphibians healextremity wounds by regeneration, a process whereby
injured tissues are reconstituted entirely without scar formation
(Brockes, 1997). Although scar formation has been thought to be an
invariable characteristic of mammalian wound healing, there is a
growing body of data documenting that, like the newt, mammals are
capable of regenerative healing of cutaneous wounds during the first
and second trimesters of development (Longaker and Adzick, 1991;
Lorenz et al, 1992; Martin, 1997); however, by birth cutaneous wound
repair is accompanied by scar formation. Fetal and adult wound healing
exhibit differences in connective tissue matrix composition, the type
of cellular migration into the wound, and growth factor gene expression
(Lorenz et al, 1995). Although it has been hypothesized that develop-
mentally restricted signals orchestrate regenerative repair (Nath et al,
1994; Hopkinson-Woolley et al, 1994), little is known about the
molecular regulation of mammalian fetal wound regeneration. Under-
standing this process would have implications not only for adult wound
healing, but also for the treatment of other diseases characterized by
scar formation as well as regeneration of damaged organs such as
injured myocardium or liver.
Amphibian limb regeneration is marked by the induction of homeo-
box gene expression (Savard et al, 1988; Brown and Brockes, 1991;
Manuscript received August 22, 1997; revised February 24, 1998; accepted
for publication March 12, 1998.
Reprint requests to: Dr. Corey Largman, Molecular Hematopoiesis Research,
San Francisco VA Medical Center, 4150 Clement Street, San Francisco,
CA 94121.
Abbreviation: RACE, rapid amplification of cDNA ends.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
57
expression was strongly increased compared with
unwounded skin and the signal was localized to the
wounded dermis, the site of scarless repair. Conversely,
in adult skin weak epidermal PRX-2 expression was
observed, mRNA levels were not increased by wounding,
and no dermal expression was detected. HOXB13 expres-
sion was decreased in wounded fetal tissue relative to
unwounded fetal controls or wounded adult skin. Thus
both HOXB13 and PRX-2 are expressed in patterns
consistent with roles in fetal skin development and
cutaneous regeneration. Key words: homeodomain/scar
formation/skin development/wound healing. J Invest Dermatol
111:57–63, 1998
Crews et al, 1995; Reginelli et al, 1995; Savard and Tremblay, 1995;
Brockes, 1997). Homeobox genes share a conserved sequence that
encodes a DNA binding homeodomain motif, and homeodomain
proteins are thought to function as transcription factors (Gehring et al,
1994). Mammalian homeobox genes are subdivided into the HOX
genes that are arrayed in four genomic loci (A, B, C, and D), and the
non-HOX genes that are dispersed throughout the genome (Burglin,
1994). Homeobox genes are thought to be master developmental
regulators on the basis of their specific temporal and spatial expression
patterns (Krumlauf, 1992), and the phenotypic changes observed in
knockout and transgenic animals (Chisaka and Capecchi, 1991; Jabs
et al, 1993). We have previously reported that both HOX and non-
HOX genes are expressed in the developing skin (Detmer et al, 1993;
Mathews et al, 1993; Stelnicki et al, 1997, 1998). While this work
was in progress, a review of wound regeneration suggested that
developmentally regulated homeobox transcription factors might play
a role in mammalian scarless fetal skin healing (Brockes, 1997).
Although both the dermis and the epidermis heal in a full-thickness
wound, there are major differences in the process of fetal and adult
dermal repair. In the adult, dermal wound healing is initiated by an
inflammatory response mediated by macrophages, which in turn attract
fibroblasts into the wound. These adult fibroblasts then lay down an
extracellular matrix consisting of mostly type I collagen in an irregular
pattern that results in scar formation over a period of weeks to months
(reviewed in Martin, 1997). In contrast, fetal dermal wound healing is
mediated by local fibroblasts, which are rapidly activated in response
to cutaneous injury (Adzick and Lorenz, 1994; Nath et al, 1994; Lorenz
et al, 1995; ). These fibroblasts deposit predominantly type III collagen
and lay down an extracellular matrix that results in the restoration of
normal architecture within 3–7 d. This process carries over to re-
epithelialization that also occurs at an accelerated rate in the fetal
wound (Lorenz and Adzick, 1993).
The purpose of this study was to identify candidate homeobox
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transcription factors that might mediate scarless wound repair. Our
criteria for potential candidates were: (i) expression in fetal fibroblasts,
the effector cells of fetal wound healing (Lorenz et al, 1995); (ii)
developmentally regulated dermal gene expression; and (iii) differential
expression in fetal scarless wounds compared with adult wounds. We
have used a reverse transcriptase polymerase chain reaction (RT-PCR)/
sequencing protocol to screen for human homeobox genes that might
mediate scarless fetal regeneration, using cultured fetal fibroblasts and
an established model of scarless fetal wound repair (Lorenz et al, 1992,
1995). This survey protocol identified two new human homeobox
genes, PRX-2 and HOXB13, which were expressed in proliferating
fetal fibroblasts and early wounded fetal skin samples. RNase protection
analysis and in situ hybridization data demonstrated that PRX-2 meets
our criteria for a potential regulator of scarless wound repair. In
addition, HOXB13 also exhibits expression patterns consistent with a
role in this process. Thus, both genes were expressed in proliferating
fibroblasts and showed specific temporal and spatial developmental
patterns of expression. Both PRX-2 and HOXB13 also showed
differential expression patterns in scarless fetal skin wounds compared
with adult scarring wounds.
MATERIALS AND METHODS
Tissue samples All tissue samples were obtained under NIH guidelines in
accordance with the regulation and approval of the University of California
San Francisco Committee on Human Research. Skin samples used for determina-
tion of homeobox gene expression during fetal skin development by RT-PCR
screening were taken from mid-second trimester (18–24 wk gestation) fetal
parietal scalp (N 5 3), back (N 5 3), or the thigh region of the leg (N 5 2).
Human fetal and adult skin wounds/SCID mouse model Mid-second
trimester (18–24 wk gestation) fetal skin from parietal scalp skin (N 5 3) or
adult (50–60 y old) scalp skin (N 5 3) was transplanted into SCID mice as
previously described (Lorenz et al, 1992). Each human tissue was divided into
three parts. One section was immediately harvested as control, untransplanted
tissue. The two other 5 mm35 mm grafts of human fetal or adult skin,
containing both epidermis and dermis, were placed into subcutaneous pockets
on the opposite sides of the back of a single animal. After 2–3 wk of healing,
one of the grafts was re-exposed, and a full thickness linear incision was made,
marked with India Ink, and the mouse skin re-closed. Contralateral grafts were
transplanted but not wounded to control for the possible effects of tissue
transplantation on the cells within the human skin sample. Under the conditions
studied, the second trimester human fetal skin heals without a scar, whereas the
adult skin heals with scar formation (Lorenz and Adzick, 1993). For the
preliminary RT-PCR screening experiments, tissues were harvested 4 and 12 h
post-wounding, whereas for RNase protection and in situ hybridization analyses
wounded and control tissue samples were harvested 12 h after the time
of wounding.
RNA isolation/RT-PCR Total RNA was isolated from skin samples using
the acidic phenol extraction method (Chomczynski and Sacchi, 1987).
Fetal scalp skin dermis and epidermis were isolated by a heat separation method
(Holleran et al, 1992). To detect transcripts for all of the HOX genes present
in each tissue, an amplified cDNA mixture was first synthesized (Sauvageau
et al, 1994). The amplified cDNA were then screened using a set of
degenerate primers designed against two highly conserved regions of the human
HOX homeobox genes: (59-GA(G/A)(T/C)T(G/A/T)GA(A/G)(C/A/G)
(G/A)(G/A/C)GA(A/G)T(A/T)(T/C)-39) and (59-NC(G/T)(A/G)TT(T/C)
TG(A/G)AACCANA(C/T)-39). This procedure produced a single, 118 bp
band that contained amplified products representing the HOX genes present in
each tissue sample, as well as some of the non-HOX homeobox genes that
might be amplified by this primer set. The polymerase chain reaction (PCR)
products were cloned and identified by sequence comparison with genbank
data and published homeobox sequences (Burglin, 1994).
cDNA cloning In order to isolate cDNA clones encoding both PRX-2 and
HOXB13, rapid amplification of cDNA ends (RACE) was performed using a
Marathon kit (Clontech, Palo Alto, CA) with RNA isolated from human fetal
fibroblasts. A 299 nt 39 extension from the 118 nt HOXB13 homeobox
fragment was isolated using a 39-RACE with a 59 forward primer (GGTTCT-
CGCCAAGGTGAAGAACAG) from the homeobox sequence along with a
39 reverse oligo-dT primer. A 916 nt 59 extension to the partial homeobox
sequence was isolated using a 59-RACE with a 39 reverse primer
(CTGGGCTTGGCAGGTTTCTGGTCTC) from the sequence identified
with the 39-RACE and a 59 forward primer supplied by the manufacturer.
A 606 nt 39 extension from the initially identified 118 nt homeobox fragment
of human PRX-2 to a polyA tail was isolated using a 39-RACE with a primer
from the homeobox (GGTTCTCGCCAAGGTGAAGAACAGC) and an
oligo-dT primer. A partial 112 nt 59 extension to the internal homeobox
sequence was isolated using a primer from the homeobox and a poly C primer
designed against a poly G sequence added to the 59 end of the initial cDNA
product (Loh et al, 1989).
Cell culture Human fetal (N 5 10, 18–24 wk) and newborn (N 5 3, 2–4
mo) fibroblasts were isolated from 2 3 2 cm sections of scalp skin by
incubation overnight at 37°C with 0.05% (vol/vol) trypsin/0.02% (vol/vol)
ethylenediamine tetraacetic acid in Dulbecco’s modified Eagle’s medium with
10% fetal calf serum, penicillin/streptomycin sulfate/amphotericin, Fungizone
(1X), and 200 mM L-glutamine. Following growth to confluence, cells were
passaged and harvested during log phase growth. Keratinocyte fractions were
isolated from newborn human scalp tissue remaining from neurosurgical
procedures, following the protocol described by Gibco (Grand Island, NY).
Cells were plated and grown in KGM-SFM containing 0.07 mM calcium to
90% confluence, passaged once and grown in KGM-SFM with 0.07 mM
calcium, and harvested in log-phase growth.
RNase protection A 400 nt fragment of the PRX-2 cDNA lacking the
homeobox was used to synthesize a 32P-labeled anti-sense probe following the
manufacturer’s protocol (Boehringer, Indianapolis, IN). A human G3PD probe
was used as an RNA loading control. Labeled probes were incubated with
RNA samples as previously described (Detmer et al, 1993). Gels were scanned
and analyzed using an NIH Image software package to quantitate
PRX-2 expression, which was normalized to the G3PD values.
RT-PCR analysis Total RNA (5 µg) from each sample was reverse
transcribed following the manufacturer’s protocol (Gibco). All PCR reactions
were assayed after different cycles to insure that the reactions were in the linear
part of the amplification curve. An internal control PCR reaction using c-Abl
PCR primers (forward primer, 59-TTCAGCGGCCAGTAGCATCTGACTT-
39; and reverse primer, 59-TCCCTCCAGCGCCGCCAGCAAG-39) was
initially performed to standardize the amount of cDNA in each sample. c-Abl
was selected as an appropriate control for RT-PCR analysis of low level gene
transcription signals (Taylor and Heasman, 1994). c-Abl signal was quantitated
by southern hybridization using an internal 32-P labeled primer (59-GGGGT-
CATTTTCACTGGGTCCAGCGAGAAGGT-39). Based on c-Abl data, equal
amounts of cDNA were added to a second PCR reaction that used specific
HOXB13 primers (forward primer, 59-GGTTCTCGCCAAGGTGAAGA-
ACAGC-39; and reverse primer, 59-GGACCACCTCACCCGACAGTGTAC-
39) and amplified for 18–20 cycles. Reaction products were quantitated by
densitometry of Southern blots hybridized to an internal HOXB13 oligomer
(59-GCCTGGGTGGGAGGAGCGAAAGTGGGGGTGTCTGGGGGAGA-
CCAGA-39).
RNA in situ hybridization A 400 nt fragment from the 39 region of the
PRX-2 cDNA, used for RNase protection, was used as a template for synthesis
of 35-S-labeled sense and anti-sense probes. In situ hybridization was performed
on paraffin embedded skin sections following standard protocols (Arbeit
et al, 1996).
Statistical analysis Statistical analysis was performed using the Student t test
with a Primer of Biostatistics computer program on a Power MacIntosh.
FISH Genomic hybridization of the P1 probe was determined using fluores-
cence in situ hybridization as described previously (Gray et al, 1992).
RESULTS
Two homeobox genes are expressed in cultured human fetal
fibroblasts Fibroblasts are thought to be the effector cells during
fetal tissue regeneration (Lorenz et al, 1995). Cultured fibroblasts
isolated from second trimester fetal skin exhibited a 2.5-fold more
rapid growth compared with newborn cells (N 5 10, data not shown).
As an initial screening assay for homeobox gene expression in cultured
fetal fibroblasts, we utilized a semiquantitative RT-PCR/sequencing
procedure with degenerate primers designed to detect all 38 of the
known human HOX gene transcripts, as well as some non-HOX
homeobox mRNA. Sequence analysis of the cloned 118 nt PCR
products, derived from an internal portion of the homeobox, was used
to identify the homeobox gene transcripts in three separate fibroblast
cultures by comparison with published sequences. This approach has
been used previously to survey homeobox gene expression in other
tissues (He et al, 1989; Vieille-Grosjean et al, 1992; Sauvageau et al,
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Figure 1. Homeobox gene expression in developing and wounded skin.
An RT-PCR protocol using degenerate oligonucleotide primers, designed
against the 38 known HOX genes as well as some non-HOX genes, was used
to detect homeobox gene expression in cultured fetal fibroblasts, second
trimester fetal skin, fetal scalp skin separated into dermis and epidermis, adult
skin, and wounded second trimester fetal skin in a mouse transplantation model
(see Materials and Methods). PCR products were cloned, sequenced, and
identified by comparison with known HOX and non-HOX gene sequences.
In addition to detection of known homeobox genes (see Results), two novel
human homeobox transcripts were detected and identified as HOXB13 and
PRX-2. j, HOXB13; u PRX-2; , other HOX and non-HOX homeobox
genes. The N values represent the number of different cDNA clones sequenced
for each tissue sample or time point.
1994). When this technique was used to qualitatively survey homeobox
gene expression in log-phase cultured second trimester fetal fibroblasts,
only two homeobox gene sequences were obtained, neither of which
corresponded to sequences present in genbank at the time of analysis
(Fig 1). The majority of these sequences were most similar to the
murine paired-like homeobox gene Prx-2 (Leussink et al, 1995), and
were subsequently shown to represent the human PRX-2 gene (see
below). The remaining sequences most closely matched those of
HOXD13 and HOXA13; and, as described below, were shown to be
derived from the previously undescribed HOXB13 homeobox gene
(Burglin, 1994). The detection of only these two homeobox gene
transcripts in cultured fetal fibroblasts was in contrast to the broad
array of homeobox mRNA detected using the same RT-PCR protocol
in fetal or adult skin (Fig 1). In addition to expression of other
homeobox genes in skin samples from second trimester scalp, back, or
leg, substantial expression of HOXB13 but very low levels of PRX-2
were detected using the RT-PCR procedure. We have recently
described the expression patterns of the many HOX genes (HOXA4,
HOXA5, HOXA6, HOXA7, HOXA10, HOXA11, HOXB1, HOXB3,
HOXB4, HOXB6, HOXB7, and HOXC4) (Stelnicki et al, 1998) as
well as the non-HOX genes (MSX-1, MSX-2, MOX-1, and Caudel)
(Stelnicki et al, 1997) reported as other homeobox genes in Fig 1.
Because many of these gene transcripts had been reported in previous
studies, these data demonstrated the utility of the RT-PCR/sequencing
approach for identifying homeobox genes in wounded tissues.
Consistent with their detection in proliferating fibroblasts, both PRX-
2 and HOXB13 were detected in the dermis of second trimester fetal
skin and were not detected in adult skin (Fig 1). It should be noted
that because this screening assay is neither quantitative nor exhaustive,
low levels of gene expression in other skin elements might not be
detected. Thus, although PRX-2 was not detected in adult skin by this
method, a low level of PRX-2 expression was observed in the adult
epidermis by in situ hybridization and RNase protection analyses
(see below).
Both PRX-2 and HOXB13 are detected in fetal wound
regeneration We next screened for homeobox gene expression
in a fetal wound regeneration model, in which second trimester fetal
or adult human scalp skin was transplanted into SCID mice. In this
model, full thickness wounds made in transplanted second trimester
fetal skin heal without scar formation, whereas wounded adult skin
heals with scarring (Lorenz et al, 1992). This model has previously
been used to show both that fetal fibroblasts are the effector cells
that mediate wound regeneration, and that there is rapid fibroblast
proliferation during the early stages of healing (0–24 h post-wounding)
(Lorenz et al, 1995). We used the degenerate primer based RT-PCR/
sequencing method in conjunction with this model to screen for
homeobox gene expression at early times during scarless repair. At
both 4 and 12 h post-wounding, over 80% of homeobox sequences
detected in three separate samples of wounded fetal skin consisted of
human PRX-2 and HOXB13 (Fig 1). It should be noted that murine
cDNA sequences resulting from contamination from the underlying
host tissue were not detected. Thus the same homeobox genes expressed
in cultured fetal fibroblasts were also detected in fetal skin immediately
post-wounding. These data provided the impetus to further characterize
and quantitatively assay these genes in normal skin and during fetal
and adult wound repair.
The paired-like homeobox gene in fetal skin is PRX-2 We first
wished to identify the novel human PRX-2-like gene that we detected
in proliferating fibroblasts and early fetal wounds. In an attempt to
obtain a full-length cDNA corresponding to the paired-like gene
transcript, 59- and 39-RACE were performed starting from the partial
118 nt homeobox clone. The 39-RACE yielded an additional 606 nt
of sequence terminating in a polyA tail. The 59-RACE was only
capable of extending the cDNA 112 nt. The composite 813 nt
cDNA encoded a putative 164 amino acid protein containing a
homeodomain, but was missing a methionine start codon (genbank
accession #U81600). Northern blot analysis of fetal fibroblasts showed
that PRX-2 was expressed as a single 1.3 kb transcript (Fig 2A),
suggesting that 400–500 nt of 59 sequence is still missing. The human
cDNA sequence shows an overall identity of 74% to murine Prx-2,
with the homeodomain and extreme 39 region being very highly
conserved and a long region of coding sequence, 39 to the homeobox
being only 55% conserved; however, the putative proteins encoded by
these two genes would be 94% identical. Given the relatively low
nucleotide homology between murine Prx-2 and the putative human
PRX-2, we performed Southern blot analysis to confirm the identity
of the human cDNA. Labeled human and murine probes yielded
identical bands for either human or murine genomic DNA, indicating
that the newly isolated gene is most probably human PRX-2 (data
not shown).
PRX-2 expression is developmentally regulated in normal
unwounded skin RNase protection analysis showed that PRX-2
was more strongly expressed in normal fetal skin than in adult skin,
and was much more strongly expressed in both fetal and adult
proliferating fibroblasts, with no detectable expression in cultured
newborn keratinocytes (Fig 2B, C). We used in situ hybridization to
further localize the expression of PRX-2 in skin. PRX-2 was barely
detected in normal fetal skin as a weak signal concentrated over the
cells of mesodermal origin within the dermal papilla of the developing
hair shaft, with no signal detected in the epidermis, and little signal
above background in the dermal tissue (Fig 3A, B). Because the
procedure used to split the skin for the RT-PCR analysis (above) will
leave the hair shafts associated with the dermis, the in situ hybridization
data are consistent with the lack of PRX-2 signal detected in the
epidermis by the RT-PCR method. In adult skin, weak PRX-2
expression was detected within the basal layers of the epidermis, with
no signal detected in the dermis (Fig 3C).
PRX-2 is upregulated in scarless human fetal wounds Following
the detection of PRX-2 transcripts in early wounded fetal skin
samples by the semiquantitative RT-PCR/sequencing approach, RNase
protection analysis was used to quantitate PRX-2 gene expression in
total RNA isolated from (i) wounded versus control transplanted fetal
skin, (ii) wounded versus control transplanted adult skin, and (iii)
untreated fetal and adult skin (Fig 2C). It is important to recognize
that the model employed entails two wounds: (i) the initial placement
of a piece of fetal or adult human skin into the SCID mice, and (ii)
the subsequent wounding of the human tissues. Therefore, an important
control was considered to be unwounded transplanted human skin
tissue. RNase protection analysis of three independent graft trans-
plantation and wounding experiments revealed a statistically significant
4-fold increase in PRX-2 expression in fetal wounds compared with
adult wounded skin transplants, as well as a significant 2.5-fold increase
compared with transplanted fetal tissue (Fig 2D). Moreover, in situ
hybridization localized the enhanced levels of PRX-2 mRNA to the
fetal dermis adjacent to the wound site (Fig 3D), whereas the control
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Figure 2. PRX-2 expression in normal and
wounded fetal and adult human skin. (A)
Northern gel analysis of PRX-2 expression in
cultured fibroblasts from second trimester fetal
skin. (B) PRX-2 expression is elevated in
cultured fibroblasts and fetal skin. RNase
protection analysis was used to quantitate
PRX-2 expression in cultured cells and fetal
and adult skin tissue. G3PD was used as an
internal control for RNA loading. (C) PRX-2
expression in unwounded skin was compared
with that in transplanted but not wounded fetal
skin and in wound skin using RNase protection
analysis. Expression in wounded and
unwounded adult skin is shown for comparison.
G3PD was used as a control for RNA loading.
(D) Quantitation of PRX-2 expression in
various wounded and control tissues. The
RNase protection analysis was scanned using a
densitometer and PRX-2 values were
normalized to G3PD expression levels. u, fetal
skin; j, adult skin; f, adult wound; r, fetal
transplanted skin; e, fetal wound; *p , 0.01;
#, p , 0.04.
sense probe showed no specific signal in the dermis (Fig 3E). There
are several lines of evidence suggesting that the signals observed in the
wounded fetal skin are from human and not murine fibroblasts: (i)
previous studies have shown that in this model the human fibroblasts
are the effector cells (Lorenz et al, 1995); (ii) Prx-2 gene expression
cannot be detected in normal murine skin fibroblasts (data not shown,
P. Stephens, unpublished observations); and (iii) when PRX-2 was
detected in the wounded samples by the RT-PCR method (above),
only human sequences were observed. Murine Prx-2, which exhibits
15% sequence difference from the human gene within the 118 nt PCR
product, and would thus have easily been recognized, was not observed.
In striking contrast to wounded fetal skin, no PRX-2 expression was
detected in the dermis of the wounded adult skin. Neither wounded
adult skin (Fig 2C, D) or transplanted adult skin (data not shown)
showed an increase in expression of PRX-2 by RNase protection. In
situ hybridization demonstrated that PRX-2 was still expressed in the
wounded adult epidermis but at levels similar to those observed in the
unwounded adult skin (Fig 3F). Thus both the magnitude and the
location of PRX-2 expression is very different in adult and fetal wounds.
HOXB13 is expressed in human fetal skin In order to identify
the apparently novel HOX gene detected by the RT-PCR analysis, a
59-RACE was used to extend the original 118 nt putative HOXB13
homeobox fragment 916 nt 59 to the homeodomain, whereas a 39-
RACE was used to isolate a 282 nt extension that terminated in a
polyA tail. The combined 1316 nt clone contained an open reading
frame encoding a 284 amino acid homeodomain protein (genbank
ascension #U81599). While this work was in progress, the cloning of
a full-length cDNA for both human and murine HOXB13 was reported
(Zeltser et al, 1996). Our combined cDNA clone extended an additional
123 nt 59 and 184 nt 39 to the reported cDNA sequence for human
HOXB13. The deduced protein sequence is 100% identical to the
published sequence except for a codon change that alters residue 211
of the putative protein from Ser to Cys. Oligonucleotide primers
derived from the non-homeobox portion of this cDNA were used to
isolate an 80–100 kb P1 human genomic fragment for use in FISH
analysis. This experiment placed the gene on chromosome 17q21.2
that is the location of the human HOXB cluster (Joyner et al, 1985;
Rabin et al, 1985), thus confirming that the HOX transcript detected
in human fetal fibroblasts and wounded fetal skin is HOXB13.
HOXB13 is expressed in normal and wounded human skin A
semiquantitative RT-PCR approach with specific primers for HOXB13
was used to estimate the relative expression levels of HOXB13 in
cultured fetal and adult fibroblasts and in fetal skin. There was
substantially more HOXB13 expression detected in cultured fetal
fibroblasts compared with cultured adult fibroblasts (Fig 4A). In
addition, HOXB13 expression was detected in skin from various
regions of the developing embryo, including scalp, back, and leg. We
also used RT-PCR to measure HOXB13 in the scarless fetal wound
healing model (Fig 4B). There was a statistically significant decrease
in HOXB13 expression in wounded second trimester fetal skin com-
pared with control fetal skin (µ3-fold, p , 0.03), and a pronounced
decrease in HOXB13 expression in the wounded fetal skin compared
with the untreated transplanted fetal skin or with adult tissue (Fig 4C).
Although it is possible that the PCR protocol could detect endogenous
murine Hoxb-13 from the host skin, signals of murine origin are
unlikely because, as noted above, the effector cells are thought to be
of human origin (Lorenz et al, 1995), and murine Hoxb-13 sequences
were never detected in the RT-PCR analysis of wounded fetal skin
from the same model. Attempts to detect HOXB13 expression using
in situ hybridization or RNase protection assays were unsuccessful.
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Figure 3. Localization of PRX-2 expression
in normal and wounded human scalp skin.
In situ hybridization, using a non-homeobox
containing probe, was used to localize PRX-2
expression. (A) Anti-sense PRX-2 probe on
second trimester fetal skin showing expression
localized to the dermal papillae (small arrow).
(B) Control sense PRX-2 probe on second
trimester fetal skin. (C) Anti-sense PRX-2 probe
on normal adult skin. (D) Anti-sense PRX-2
probe on wounded second trimester fetal skin,
showing upregulation of the signal for PRX-2.
The thick arrow represents birefringence from
the India Ink used to mark the wound site.
Note that the majority of PRX-2 expression is
in the dermis. (E) Control sense PRX-2 probe
on wounded second trimester fetal skin. The
strong signal seen in the middle of the section
represents birefringence from the India Ink used
to mark the wound site. Note there is no signal
in the dermis surrounding the wound site as
seen in (D). (F) Anti-sense PRX-2 probe on
wounded adult skin. In contrast to the fetal
skin, there is moderate upregulation of PRX-2
that is localized to the epidermis, with essentially
no signal in the dermis surrounding the wound
site (arrow). The strong signal in the stratum
corneum is non-specific birefringence.
DISCUSSION
We have identified two human homeobox genes, PRX-2 and HOXB13,
which are expressed in fetal skin and that we believe are candidate
molecular regulators for aspects of scarless fetal wound healing. Both
genes are expressed in proliferating fibroblasts and fetal dermis, but not
in adult dermis, and show marked expression changes in scarless fetal
healing but not in adult scarring wounds. These data suggest that, just
as changes in homeobox gene expression have been proposed to be
important for amphibian limb regeneration (Savard and Tremblay,
1995; Brockes, 1997), these two human homeobox genes might
well influence both normal fetal skin development and cutaneous
regeneration in response to wounding. Two homeobox genes from
the POU domain subclass, Skn-1 and Tst-1, have recently been shown
to play a role in skin differentiation and were implicated in adult
wound repair (Andersen et al, 1997). The possible role of these genes
in fetal skin regeneration was not examined.
Although previous studies have localized murine Prx-2 gene expres-
sion to a range of mesodermal tissues and specifically to fibroblasts
(de Jong and Meijlink, 1993), neither expression in skin nor any
correlation with proliferation has been reported (Opstelten et al, 1991;
Leussink et al, 1995). Within the normal fetal skin, PRX-2 expression
is localized to cells of mesodermal origin at the base of the dermal
papillae. These cells have been implicated in transmitting proliferative
signals from the putative stem cells within the follicular bulge area to
the transit amplifying proliferative cells of the matrix during the hair
cycle (Cotsarelis et al, 1990). Placing fetal fibroblasts into culture
conditions in which they undergo rapid proliferation appears to
upregulate PRX-2 mRNA levels. Surprisingly, growth of newborn
fibroblasts in culture also led to high levels of PRX-2 expression. The
lack of PRX-2 expression in normal adult dermis may reflect the fact
that cells within this layer do not exhibit rapid turnover. In this regard,
in separate experiments, we have observed that Prx-2 expression in
cultured murine fibroblasts is correlated with proliferative state, and
that growth to quiescence downregulates gene expression (P. Stephens
and C. Largman, unpublished observations). The low level of PRX-2
expression in normal adult skin is restricted to the basal cell layer of
the epidermis. Because the highly proliferative transit amplifying cells
within the epidermis originate in the basal layer (Jones and Watt,
1993), it is possible that PRX-2 also plays a role in proliferation within
this layer. The finding that PRX-2 expression is not detected in
cultured newborn keratinocytes may reflect either low expression, or
that epidermal PRX-2 expression may be modulated by signals from
the dermis. Alternatively, both the lack of PRX-2 mRNA in cultured
keratinocytes and the absence of expression of other HOX and non-
HOX homeobox genes in the cultured fibroblasts may reflect artifacts
due to the nature of the culture conditions. The expression patterns
of PRX-2 in regenerating fetal wounds compared with adult wounds
provides additional evidence for a possible role in cellular proliferation.
The group that described the partial cDNA clone for murine PRX-
2 reported that they were unable to obtain a DNA sequence that
extended 59 from the homeodomain at precisely the point at which
we were unable to extend the human clone (Opstelten et al, 1991;
Leussink et al, 1995). Although these data suggested that there was
some type of secondary structure that made it difficult to clone the
missing portion of the gene that encodes the N-terminal region of
the putative PRX-2 protein, Meijlink et al have recently reported the
successful cloning of a full-length murine Prx-2 cDNA.1 This group
also reported that murine Prx-2 is expressed in the mesoderm of the
developing heart and in stromal cells of the developing bone marrow,
which is consistent with our localization of human PRX-2 gene
expression within the developing dermal layer. It is intriguing that fetal
bone is one of the other mammalian tissues that is capable of
regenerating itself after wounding with normal architecture, implying
that the putative role of PRX-2 in these two processes might be similar
(Longaker et al, 1992).
It is more difficult to assess the possible role(s) of HOXB13 in
1Fritz Meijlink, Netherlands Institute of Developmental Biology, Utrecht,
Netherlands, personal communication.
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Figure 4. HOXB13 is downregulated in scarless wound healing. (A)
Semi-quantitative RT-PCR was used to estimate HOXB13 expression in
cultured fetal and adult fibroblasts, in newborn keratinocytes, and in
representative samples of second trimester fetal skin. c-Abl was measured in an
independent PCR to quantitate cDNA. RT, reverse transcriptase. (B) RT-PCR
was used to compare HOXB13 message levels in normal skin, transplanted but
not wounded skin, and wounded second trimester fetal or adult skin. A
radiolabeled internal primer was used to detect HOXB13 expression by Southern
blotting of the PCR products. A labeled internal primer to c-Abl was used to
quantitate the specific amplification of this transcript in a separate PCR. (C)
Quantitation of HOXB13 expression in the various wounded and control skin
tissues. j, Adult skin; o, fetal skin; r, fetal transplanted skin; f, adult wounded
skin; e, fetal wounded skin. Gels from the Southern analysis of the PCR
reactions were scanned and quantitated. HOXB13 values were normalized to
the c-Abl levels. Means and SD are reported. *p , 0.01.
normal skin because it was not possible to localize the transcripts by
in situ hybridization. In this regard, we note that the authors who
described the cloning of the HOXB13 cDNA also did not report
detection by northern analysis or RNase protection, but only reported
the localization of very weak signal to the distal end of the growing
spinal cord by whole-mount in situ hybridization (Zeltser et al, 1996).
Thus, these data are consistent with our findings that the HOXB13
gene is expressed at low levels in skin. In contrast to PRX-2, the low
level of HOXB13 gene expression is further downregulated in scarless
fetal wound healing compared with adult healing. We have recently
demonstrated that the HOXB13 protein forms complexes with the
non-HOX homeodomain protein Meis1 and stabilizes the DNA
binding of Meis1 (Shen et al, 1997). We are currently assessing the
expression of Meis1 in fetal and adult skin. While this work was in
review, Godwin and Capecchi demonstrated that mice lacking the
HOXC13 gene demonstrate severe abnormalities in hair formation
and growth (Godwin and Capecchi, 1998). The HOXC13 protein is
expected, on the basis of sequence homology, to bind to identical
DNA elements as the HOXB13 protein described in this study (Shen
et al, 1997). Thus the finding that HOXC13 plays a role in hair
development might suggest a similar role for HOXB13. It should be
noted that we did not detect HOXC13 gene expression in either
normal developing skin or fetal wounds.
Previous studies have suggested that homeobox gene expression can
influence cellular proliferation (Lawrence et al, 1996). Over-expression
of HOXB8 (Perkins et al, 1990) or HOXA10 (Thorsteinsdottir et al,
1997) in bone marrow cells induces hyper-proliferation, which leads
to acute leukemias. Interestingly, this is not a general phenomenon of
all HOX genes, because HOXB4 did not induce leukemias but
produced a selective expansion of the marrow stem cell pool (Sauvageau
et al, 1995). Similarly, over-expression of HOXB3 in bone marrow
induced a myeloproliferative state that did not progress to leukemia
(Sauvageau et al, 1997). HOXB7 expression was shown to correlate
with melanoma cell proliferation, and blockade of HOXB7 induced
cellular quiescence (Care et al, 1996). In these cells, HOXB7 appeared
to directly regulate the levels of bFGF mRNA.
In order to effect wound regeneration rather than wound scar
formation, the migration, proliferation, and differentiation of fetal
fibroblasts must predominate over infiltration, proliferation, and activa-
tion of wound macrophages, the principle early component of adult
wound healing (Lorenz et al, 1995). The few targets that have been
identified for homeodomain proteins suggest mechanisms by which
these genes might modulate fetal wound regeneration. Cell surface
adhesion molecules have been implicated as potential targets for
transcriptional regulation by homeodomain proteins (Jones et al, 1992,
1993; Gould and White, 1992; Tomotsune et al, 1993; Goomer et al,
1994). Adhesion molecules modulate a repertoire of processes, such as
cell proliferation, migration, and intercellular contacts, each of which
may contribute to enhanced early contribution of the fetal fibroblast
to wound healing. Indeed, Tenacin, part of the extracellular matrix
that is rapidly deposited during fetal wound healing, is also regulated
in vitro by homeodomain proteins (Edelman and Jones, 1992). In
Drosophila, homeodomain proteins regulate the expression of a TGF-
β-like molecule (dpp) that is most closely related to mammalian BMP-
2 (Immergluck et al, 1990). In addition, homeobox gene expression
patterns exhibit close spatial and temporal relationships with both BMP
and fibroblast growth factors (Francis et al, 1994; Vogel et al, 1995).
Controlled deposition of these growth factors in the matrix of fetal
wounds may create a microenvironment that is conducive to the early
colonization of the fetal wound by fibroblasts versus macrophages. We
hypothesize that the function of PRX-2 and HOXB13 in the fetal
fibroblast is to activate or repress diffusible signals that control the
process of tissue growth and development. Moreover, the changes
observed in expression of these genes during fetal but not adult wound
healing suggest a possible role for the protein products in mechanisms
that control mammalian dermal regeneration and prevent the formation
of scar response to wounding. Understanding this process would
provide the first step not only in controlling scar formation, but also
in treating fibroproliferative diseases such as cirrhosis, as well as in the
eventual realization of the long sought goal of possible induction of
mammalian tissue regeneration.
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